Back to today’s briefing

Story perspectives

NIH Funding Cuts Threaten Drug Innovation and Access

6/5/2025

42 5

Summary

Story summary

Darius Lakdawalla, PhD, raises alarms over NIH funding cuts and looming tariffs threatening the pharmaceutical industry. He argues that these reductions could stifle medical innovation and limit patient access to vital treatments. Advocating for creative pricing strategies, Lakdawalla stresses the importance of a stable FDA review process to secure timely and affordable drug approvals for all.

1 of 1

Story summary

Darius Lakdawalla, PhD, raises alarms over NIH funding cuts and looming tariffs threatening the pharmaceutical industry. He argues that these reductions could stifle medical innovation and limit patient access to vital treatments. Advocating for creative pricing strategies, Lakdawalla stresses the importance of a stable FDA review process to secure timely and affordable drug approvals for all.